ERICA RIVERA-ARMOREDA: Open Payments
NPI 1588864953 · KENNESAW, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 57 payments from 13 companies in 2025. Trend: 2023 $669 · 2024 $868 · 2025 $1,063
Food & beverage: $1,063
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $217 |
| Lilly USA, LLC | 11 | $207 |
| ABBVIE INC. | 14 | $206 |
| PFIZER INC. | 5 | $133 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Dynavax Technologies Corporation | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: VRAYLAR, Ozempic, NURTEC ODT, MOUNJARO, CAPLYTA, JARDIANCE, Wegovy, Heplisav-B.
Industry payments across GA — which companies pay providers there.
